Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Leping Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9614-9066; OpenAlex author ID A5047030483. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers

Papers 8

  1. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing… First author DOI 10.1002/cam4.3627↗
  2. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer. Co-author DOI 10.1177/15353702211023473↗
  3. Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Last author DOI 10.1016/j.biocel.2020.105731↗
  4. Baicalein flavone targets cisplatin resistant human pancreatic cancer cells via inducing S-phase cell cycle arrest, inhibition of cell migration and invasion, … Last author PMID 33099937↗
  5. MiR-590-5p sensitises pancreatic ductal adenocarcinoma cells by blocking autophagy via targeting ATG3 Last author DOI 10.1101/548610↗
  6. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.3233/cbm-160655↗
  7. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Co-author DOI 10.3233/cbm-150515↗
  8. Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague-Dawley rats. Co-author DOI 10.1186/1477-7819-12-32↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuyang Hou · 3 shared papers, 2020–2021 · strength 0.41
  2. Jun He · 3 shared papers, 2020–2021 · strength 0.41
  3. Xiongying Miao · 4 shared papers, 2014–2020 · strength 0.30
  4. Yan Zhou · 2 shared papers, 2020–2021 · strength 0.26
  5. Fanhua Kong · 2 shared papers, 2020–2021 · strength 0.26
  6. Daming Li · 1 shared paper, 2021 · strength 0.15
  7. Kunpeng Wang · 1 shared paper, 2021 · strength 0.14
  8. Yawei Zhang · 1 shared paper, 2020 · strength 0.13
  9. Fazhao Li · 1 shared paper, 2019 · strength 0.12
  10. Qiong Zou · 2 shared papers, 2015–2016 · strength 0.11
  11. Yuan Yuan Ma · 2 shared papers, 2015–2016 · strength 0.11
  12. Hongliang Yao · 1 shared paper, 2016 · strength 0.06
  13. Xingguo Tan · 1 shared paper, 2014 · strength 0.06
  14. Chun Liu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.